Radcliffe Capital Management’s Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share TCOA.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding TCOA.WS
SCM
6CM
PAMP
PC
AC
CS
ACM
CSS
Radcliffe Capital Management's TCOA.WS Position: Q2 2024 in Review
Radcliffe Capital Management sold out of Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share (TCOA.WS) in Q2 2024, closing a stake of 581,439 shares — an estimated $29.2K sold.
Radcliffe Capital Management first reported a position in TCOA.WS in Q1 2022 and held it in 9 quarters. The position peaked at $7.21M in Q4 2022. 19 funds tracked by Wall St. Rank hold TCOA.WS as of Q2 2024.
- Radcliffe Capital Management reported no remaining Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position as of Q2 2024 after selling out during the quarter.
- Radcliffe Capital Management sold 581,439 Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share shares in Q2 2024, an estimated $29.2K.
- Radcliffe Capital Management first reported a position in Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share in Q1 2022 and held it in 9 quarters.
- Radcliffe Capital Management's Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share position peaked at $7.21M in Q4 2022.
- 19 funds tracked by Wall St. Rank held Zalatoris Acquisition Corp. Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share as of Q2 2024.
Based on Radcliffe Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.